Role of inflammation in initiation and maintenance of atrial fibrillation in rheumatic mitral stenosis - An analytical cross-sectional study
Open Access
- 1 December 2020
- journal article
- research article
- Published by Wiley in Journal of Arrhythmia
- Vol. 36 (6) , 1007-1015
Abstract
Background: Inflammation has been implicated in the initiation and perpetuation of non-valvular atrial fibrillation (AF). However, there is a lack of similar data on AF in rheumatic heart disease (RHD). The objective of this study was to analyze the association of inflammation as measured by serum inflammatory biomarkers with AF in rheumatic mitral stenosis (Rh-MS). Methods: A comparative cross-sectional analytical study was conducted on 181 Rh-MS patients in normal sinus rhythm (NSR; n = 69), subclinical transient AF (SCAF; detected by 24-hours Holter monitoring; n = 30) and chronic AF (n = 82). Serum hs-CRP, IL-6, and sCD-40L were assessed using ELISA immunoassay and compared in all groups of Rh-MS with or without AF. Results: We found significantly higher serum hs-CRP and sCD-40L levels in the overall AF (Chronic AF + SCAF) group (hs-CRP: 4.5 +/- 3.4 vs 2.3 +/- 2.9 mg/L,P sCD-40L: 6.4 +/- 4.8 vs 3.1 +/- 3.4 ng/mL,P < .01) and chronic AF subgroup (hs-CRP: 4.9 +/- 3.4 vs 2.3 +/- 2.9 mg/L,P sCD-40L: 6.9 +/- 5.1 vs 3.1 +/- 3.4 ng/mL, P < .01) compared to patients with sinus rhythm. There was a statistically significant graded increase of serum IL-6 level from the NSR to the SCAF (vs NSR: 6.8 +/- 3.9 vs 4.0 +/- 2.2 pg/mL,P = .03), and chronic AF subgroups (vs NSR: 9.3 +/- 6.5 vs 4.0 +/- 2.2 pg/mL,P SCAF: 9.3 +/- 6.5 vs 6.8 +/- 3.9,P = .05) of atrial fibrillation. Conclusions: Elevated levels of serum hs-CRP, IL-6, and sCD-40L were strongly associated with overall AF and also with SCAF and chronic AF in Rh-MS patients indicating a potential role of inflammation in the pathophysiology of rheumatic AF.Keywords
Funding Information
- Indian Council of Medical Research (5/4/1‐3/12‐NCD‐II)
This publication has 30 references indexed in Scilit:
- Inflammatory cytokines and atrial fibrillation: current and prospective viewsJournal of Inflammation Research, 2010
- Interleukin-6 and atrial fibrillation in patients with coronary artery disease: Data from the Heart and Soul StudyAmerican Heart Journal, 2008
- Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillationEP Europace, 2008
- ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart DiseaseCirculation, 2006
- High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversionInternational Journal of Cardiology, 2006
- Is atrial fibrillation an inflammatory disorder?European Heart Journal, 2005
- Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammationInternational Journal of Cardiology, 2005
- Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillationThe American Journal of Cardiology, 2005
- C-reactive Protein and Atrial Fibrillation Is inflammation a consequence or a cause of atrial fibrillation?Japanese Heart Journal, 2004
- Prevalence and predictors of atrial fibrillation in rheumatic valvular heart diseaseThe American Journal of Cardiology, 1996